Health and Government Operations Committee advances package of health, insurance and tech bills; prior-authorization proposal held

The House Health and Government Operations Committee, chaired by Jocelyn Pena Melnick, advanced a series of bills during a midday voting session and held one measure for further review.

The most substantive actions included approval of a hospital staffing bill requiring facility-level clinical staffing committees (House Bill 905), passage of a bill permitting hospitals to sell certain patient medical debt to government units or nonprofit organizations for the sole purpose of cancelling that debt (House Bill 765), and approval of a data-governance measure to codify the State Chief Data Officer and an Office of Enterprise Data within the Department of Information Technology (House Bill 807). The committee also approved measures on anesthesia coverage, specialty‑drug reimbursement arrangements, and a buprenorphine training grant program; members postponed a vote on a bill that would bar providers from charging patients fees for prior authorization requests and had removed proposed AI provisions (House Bill 1314).

Why it matters: Several bills affect hospital operations and patient financial protections. HB 905 would require hospitals to create clinical staffing committees with balanced management and employee membership and to develop, implement and annually review staffing plans; the law includes a phased start (development in 2026, implementation on or before Jan. 1, 2027 for some provisions) and a reporting obligation by the Maryland Hospital Association beginning July 1, 2029. HB 765 creates a pathway for hospitals to sell patient balances to entities that will cancel debt, and the provision is slated to sunset Dec. 31, 2027.

Details from the session

House Bill 905 (clinical staffing committees): The bill, as amended, requires each hospital to establish a clinical staffing committee with equal membership for management and employees, to develop an annual clinical staffing plan and to consider evidence‑based standards, existing staffing levels and methods to fill coverage gaps when creating the plan. The amendments require inclusion of at least one staff physician who is not a hospital employee or administrator and move full implementation dates to a phased schedule (plans developed in 2026, implementation deadlines beginning Jan. 1, 2027). The bill also requires the Maryland Hospital Association to compile yearly summaries from hospitals beginning July 1, 2029, and transmit them to the Senate Finance and House Health and Government Operations committees. The committee moved the bill as amended and recorded no detailed roll call in the transcript; several members were noted as declining co‑sponsorship.

House Bill 765 (sale of hospital medical debt): As amended, the bill allows a hospital to sell patient debt for hospital services to a government unit, a contractor of a government unit, or a nonprofit organization if the contract states that the sole purpose of the sale is to cancel the debt. The bill specifies that patients are not responsible for any sold debt or associated interest, fees or costs, directs the HSCRC to treat payments to hospitals for debt as offsets to reported uncompensated care and sunsets on Dec. 31, 2027. Delegate Kerr moved the amendments; Delegate Kipke stated he would vote no.

House Bill 32 (forensic review boards): The committee approved legislation requiring the Maryland Department of Health to establish a forensic review board at facilities that have persons committed as not criminally responsible (NCR) to review eligibility for discharge or conditional release. The version before the committee removed a provision that would have codified a community forensic aftercare program within MDH; committee discussion indicated that excising that aftercare piece removed the bill’s fiscal impact. Delia Bagnell, the subcommittee chair, said the sponsor had worked with stakeholders and that removing the aftercare program eliminated the fiscal note.

House Bill 1131 (buprenorphine training grant program): The bill would create a grant program in MDH to offset county costs to train paramedics to administer buprenorphine. The governor must include an appropriation of at least $50,000 from the Opioid Restitution Fund for the program. The Maryland Office of Overdose Response must form a work group to study access to buprenorphine and report to the General Assembly by Dec. 31, 2025. The committee moved the bill without recorded dissent.

House Bill 1086 (anesthesia time limits): The committee approved an amendment-clarified bill that prohibits carriers and Medicaid from placing time limitations on the delivery of anesthesia when anesthesia for a procedure is covered; the amendments make clear coverage includes care immediately before and after a procedure.

House Bill 1243 and 1246 (specialty drugs; cost‑sharing contributions): The committee advanced measures addressing specialty‑drug reimbursement and the treatment of manufacturer or voucher assistance when calculating an insured’s cost‑sharing. HB 1243 prohibits carriers and PBM arrangements from excluding coverage for specialty drugs administered or dispensed by a provider under specified circumstances and contains clarifying language about HSCRC rate authority. HB 1246 requires certain carriers to include manufacturer discounts, vouchers or other financial assistance toward an enrollee’s cost‑sharing contribution, requires notice to enrollees of maximum assistance and exempts charitable organizations from some notice/continuation requirements.

House Bill 1314 (prior authorization fees and AI): Committee members heard questions about whether charging patients a fee for prior authorization is already illegal and whether administrative payments from insurers fully cover administrative tasks. Committee members agreed to hold the bill for additional information and follow‑up with the Maryland Insurance Administration; the committee did not take a final vote on HB 1314 during this session.

Other measures: The committee advanced a departmental bill codifying the Office of Enterprise Data and the State Chief Data Officer (HB 807), repealed an interdepartmental advisory committee related to minority and women business affairs (HB 826), and created a pharmacy benefit manager work group to study PBM issues (HB 813). Several bills were noted as coming out of subcommittee "favorable with amendment."

Quotes and attributions

"This was a lot of work; the bill sponsor worked really hard with all the stakeholders," Delia Bagnell said while moving amendments to HB 32, noting that removal of the aftercare program eliminated the fiscal note.

Committee chair Jocelyn Pena Melnick opened the session and framed the vote as a full‑committee confirmation of subcommittee work: "For those of you in the audience that have not seen us vote before ... these bills have been fully vetted in subcommittee." (committee opening remarks)

What’s next: The committee signaled additional voting sessions and asked members and staff to follow up on unanswered questions, especially on the prior‑authorization bill. Several bills include reporting or sunset dates that will require monitoring by the House committees named in the statutes.

Methodology and limitations: This summary is based on the committee’s recorded voting session transcript. Where the transcript did not provide full roll‑call tallies, the article notes either the absence of a recorded roll call or specific members who stated opposition. The committee often announced that votes came out of subcommittee and then took a final committee vote; this article records committee actions and dates or deadlines that were stated on the record.